Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
This trial is conducted in Europe. The aim of this observational study is to evaluate the
 change in weight in type 2 diabetes patients using Levemir® or Insulatard® under normal
 clinical practice conditions.
Inclusion Criteria:

 -  Type 2 diabetes

 -  HbA1c greater than 7.0% and/or hypoglycaemia

 -  variable FBG and/or weight increase

 -  the selection of the subjects will be at the discretion of the participating physician

 Exclusion Criteria:

 -  non-type 2 diabetes

 -  current treatment with Levemir® or Insulatard®

 -  hypersensitivity to Levemir® or Insulatard® or to any of the excipients

 -  women who are pregnant, breast feeding or have the intention of becoming pregnant
 within next 6 months